iShares Evolved U.S. Innovative Healthcare ETF is a ETF series of iShares U.S. ETF Trust (series S000061258). Net assets $36.8M as of 2022-07-31.
Showing 15 of 200 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Johnson & Johnson | — | $3.8M | 1024.30% |
| BLACKROCK CASH FUNDS TREASURY SL AGENCY SHARES | — | $2.8M | 772.60% |
| Eli Lilly & Co | — | $2.8M | 754.56% |
| AbbVie Inc | — | $2.2M | 608.25% |
| Merck & Co Inc | — | $2.1M | 577.42% |
| Bristol-Myers Squibb Co | — | $2.0M | 536.10% |
| Vertex Pharmaceuticals Inc | — | $1.9M | 512.57% |
| Moderna Inc | — | $1.7M | 450.09% |
| Amgen Inc | — | $1.6M | 438.50% |
| Gilead Sciences Inc | — | $1.5M | 400.99% |
| Regeneron Pharmaceuticals Inc | — | $1.5M | 395.80% |
| Zoetis Inc | — | $913K | 248.08% |
| Biogen Inc | — | $843K | 229.18% |
| Seagen Inc | — | $672K | 182.69% |
| Alnylam Pharmaceuticals Inc | — | $542K | 147.27% |
| Report date | Net assets |
|---|---|
| 2022-07-31 | $36.8M |
| 2022-04-30 | $34.0M |
| 2022-01-31 | $39.8M |
| 2021-10-31 | $42.6M |
| 2021-07-31 | $39.4M |
| 2021-04-30 | $36.3M |
| 2021-01-31 | $35.3M |
| 2020-10-31 | $24.6M |